Real-time enrollment status for this type 2 diabetes mellitus clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 10:11 AM UTC
| NCT Number | NCT07662044 |
| Recruiting Status | Recruiting |
| Condition | Type 2 Diabetes Mellitus |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 27 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 4, 2026 (3 weeks ago) |
As of August 30, 2026: Clinical trial NCT07662044 is currently recruiting participants. This phase3 study for type 2 diabetes mellitus is actively seeking new participants at 27 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07662044 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07662044 was last updated 3 weeks ago (August 4, 2026). HelloStudys verifies this status automatically.